NRNP 6645 DIAGNOSING, AND TREATING PATIENTS WITH NEUROCOGNITIVE DISORDERS

NRNP 6645 DIAGNOSING, AND TREATING PATIENTS WITH NEUROCOGNITIVE DISORDERS

nrnp 6645 diagnosing, and treating patients with neurocognitive disorders

Neurocognitive disorders (NCDs) such as delirium, dementia, and amnestic disorders are more prevalent in older adults. As the population ages and as life expectancy in the United States continues to increase, the incidence of these disorders will continue to increase. Cognitive functioning in such areas as memory, language, orientation, judgment, and problem solving are affected in clients with NCDs. Caring for someone with a neurocognitive disorder is not only challenging for the clinician; it is stressful for the family as well. The PMHNP needs to consider not only the patient but also the “family as patient.” Collaboration with primary care providers and specialty providers is essential. Anticipatory guidance also becomes extremely important.

RESOURCES

nrnp 6645 diagnosing, and treating patients with neurocognitive disorders

Be sure to review the Learning Resources before completing this activity.
Click the weekly resources link to access the resources.

WEEKLY RESOURCES

online nursing essays

Struggling to Meet Your Deadline?

Get your assignment on NRNP 6645 DIAGNOSING, AND TREATING PATIENTS WITH NEUROCOGNITIVE DISORDERS done on time by medical experts. Don’t wait – ORDER NOW!

 

There is no Assignment due this week. You should review this week’s Learning Resources and consider the insights they provide about assessing, diagnosing, and treating neurocognitive disorders. Use this quiet week to work on your practicum assignment if you are taking both courses concurrently.

Having Trouble Meeting Your Deadline?

Get your assignment on NRNP 6645 DIAGNOSING, AND TREATING PATIENTS WITH NEUROCOGNITIVE DISORDERS  completed on time. avoid delay and – ORDER NOW

LEARNING RESOURCES

  • Sadock, B. J., Sadock, V. A., & Ruiz, P. (2015). Kaplan & Sadock’s synopsis of psychiatry (11th ed.). Wolters Kluwer.
    • Chapter 21, “Neurocognitive Disorders”
  • Zakhari, R. (2020). The psychiatric-mental health nurse practitioner certification review manual. Springer.
    • Chapter 8, “Delirium and Neurocognitive Disorders”

Review the FDA-approved use of the following medicines related to treating neurocognitive disorders.

Alzheimer’s disease Delirium Parkinson’s disease dementia/psychosis
caprylidene
donepezil
galantamine
memantine
rivastigmine
There are no FDA-approved medications for the treatment of delirium. nuplazid
rivastigmine
pimavanserin

Similar Posts